Interleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid Tumors
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Male Breast Cancer|Recurrent Breast Cancer|Recurrent Endometrial Carcinoma|Recurrent Gastric Cancer|Recurrent Non-small Cell Lung Cancer|Recurrent Ovarian Epithelial Cancer|Recurrent Small Cell Lung Cancer
Interventions: BIOLOGICAL: trastuzumab|DRUG: paclitaxel|BIOLOGICAL: recombinant interleukin-12
Sponsor: National Cancer Institute (NCI)